A CRISPR Covid test ready for market
(World News Science)

PT Jyothi Datta A diagnostic test that uses an indigenously developed CRISPR technology to detect the genomic sequence of the SARS-CoV-2 virus is set to hit the domestic market. The Tata CRISPR test, powered by CSIR-IGIB FELUDA, received the Drug Controller General of India`s approval for commercial launch, as per the Indian Council of Medical Research guidelines, a note from the Tata Group...